Peculiarities and prognostic significance of epithelial-mesenchymal transition in secondary edematous breast cancers
Background. Secondary edematous breast cancers (SEBC) do not possess distinct morphological or molecular characteristics, yet they are marked by more aggressive biological behavior compared to non-edematous forms. The issue of identifying morphological and molecular-biological criteria for SEBC that...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
V. N. Karazin Kharkiv National University
2025-06-01
|
| Series: | Journal of V. N. Karazin Kharkiv National University: Series Medicine |
| Subjects: | |
| Online Access: | https://ukrmedsci.com/index.php/visnyk/article/view/229 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849230163239239680 |
|---|---|
| author | O.M. Bilyi І.І. Yakovtsova І.V. Ivakhno |
| author_facet | O.M. Bilyi І.І. Yakovtsova І.V. Ivakhno |
| author_sort | O.M. Bilyi |
| collection | DOAJ |
| description | Background. Secondary edematous breast cancers (SEBC) do not possess distinct morphological or molecular characteristics, yet they are marked by more aggressive biological behavior compared to non-edematous forms. The issue of identifying morphological and molecular-biological criteria for SEBC that determine the clinical behavior of tumors remains unresolved.
Purpose – was to investigate the peculiarities and prognostic significance of epithelialmesenchymal transition in SEBC.
Materials and methods. Two study groups were formed: Group I – SEBC (30 cases) and Group II – 15 patients with locally advanced non-edematous breast cancer at stages T3-4N1-3M0. The parameters studied included: expression of pancytokeratin, cytokeratin 18 (CK18), E-cadherin, vimentin, N-cadherin, and the stage of epithelialmesenchymal transition (EMT).
Results. In SEBC, all cases showed a positive reaction of cancer cells to pancytokeratin, while a heterogeneous reaction to CK18 was observed, which was statistically significantly lower in SEBC compared to the control group. A decrease in E-cadherin expression in SEBC was also demonstrated (p < 0.05), with 46.6% of cases showing a negative reaction, which was accompanied by the appearance of N-cadherin expression in 50% of SEBC cases. A negative correlation between N-cadherin and E-cadherin expression was identified (r = -0.46, p < 0.03). The prognostic significance of E-cadherin expression was also established. It was shown that metastatic SEBCs are characterized by reduced E-cadherin expression (χ² = 8.8, p < 0.05). Aberrant vimentin expression in the cytoplasm of cancer cells was found in 43.3% of SEBC cases. Based on the co-expression of epithelial phenotype markers (CK18 and E-cadherin) and mesenchymal phenotype markers (vimentin and N-cadherin), SEBC cases were classified according to EMT stage. EMT was absent in 36.6% of SEBC cases. No statistically significant association was found between the presence of EMT and the group affiliation of breast cancer (χ² = 0.4, p = 0.51). However, SEBC was characterized by a higher EMT stage. EMT stages 0–1 were observed in 46.6% of SEBC cases versus 93.3% in nonedematous breast cancer (χ² = 8.6, p < 0.01).
Conclusions. SEBC is characterized by heterogeneous expression of cytokeratin 18, with significantly lower levels compared to the control group. A decrease in E-cadherin expression was also established (p < 0.05), which has prognostic value: metastatic SEBC cases showed a more pronounced decrease in E-cadherin levels (χ² = 8.8; p < 0.05). No correlation was found between the presence of EMT and breast cancer group affiliation (χ² = 0.4; p = 0.51), although SEBC demonstrated a higher EMT stage. |
| format | Article |
| id | doaj-art-72b2cff6e7fc40ea9a05e7bceb6cae37 |
| institution | Kabale University |
| issn | 2313-6693 2313-2396 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | V. N. Karazin Kharkiv National University |
| record_format | Article |
| series | Journal of V. N. Karazin Kharkiv National University: Series Medicine |
| spelling | doaj-art-72b2cff6e7fc40ea9a05e7bceb6cae372025-08-21T10:35:51ZengV. N. Karazin Kharkiv National UniversityJournal of V. N. Karazin Kharkiv National University: Series Medicine2313-66932313-23962025-06-01333(54)396406https://doi.org/10.26565/2313-6693-2025-54-08Peculiarities and prognostic significance of epithelial-mesenchymal transition in secondary edematous breast cancersO.M. Bilyi0https://orcid.org/0000-0001-6267-0331І.І. Yakovtsova1https://orcid.org/0000-0002-1027-9215І.V. Ivakhno2https://orcid.org/0000-0002-5229-0068V.N. Karazin Kharkiv National University of the Ministry of Education and Science of Ukraine, Kharkiv, UkraineKharkiv National Medical University of the Ministry of Health of Ukraine, Kharkiv, UkraineKharkiv National Medical University of the Ministry of Health of Ukraine, Kharkiv, UkraineBackground. Secondary edematous breast cancers (SEBC) do not possess distinct morphological or molecular characteristics, yet they are marked by more aggressive biological behavior compared to non-edematous forms. The issue of identifying morphological and molecular-biological criteria for SEBC that determine the clinical behavior of tumors remains unresolved. Purpose – was to investigate the peculiarities and prognostic significance of epithelialmesenchymal transition in SEBC. Materials and methods. Two study groups were formed: Group I – SEBC (30 cases) and Group II – 15 patients with locally advanced non-edematous breast cancer at stages T3-4N1-3M0. The parameters studied included: expression of pancytokeratin, cytokeratin 18 (CK18), E-cadherin, vimentin, N-cadherin, and the stage of epithelialmesenchymal transition (EMT). Results. In SEBC, all cases showed a positive reaction of cancer cells to pancytokeratin, while a heterogeneous reaction to CK18 was observed, which was statistically significantly lower in SEBC compared to the control group. A decrease in E-cadherin expression in SEBC was also demonstrated (p < 0.05), with 46.6% of cases showing a negative reaction, which was accompanied by the appearance of N-cadherin expression in 50% of SEBC cases. A negative correlation between N-cadherin and E-cadherin expression was identified (r = -0.46, p < 0.03). The prognostic significance of E-cadherin expression was also established. It was shown that metastatic SEBCs are characterized by reduced E-cadherin expression (χ² = 8.8, p < 0.05). Aberrant vimentin expression in the cytoplasm of cancer cells was found in 43.3% of SEBC cases. Based on the co-expression of epithelial phenotype markers (CK18 and E-cadherin) and mesenchymal phenotype markers (vimentin and N-cadherin), SEBC cases were classified according to EMT stage. EMT was absent in 36.6% of SEBC cases. No statistically significant association was found between the presence of EMT and the group affiliation of breast cancer (χ² = 0.4, p = 0.51). However, SEBC was characterized by a higher EMT stage. EMT stages 0–1 were observed in 46.6% of SEBC cases versus 93.3% in nonedematous breast cancer (χ² = 8.6, p < 0.01). Conclusions. SEBC is characterized by heterogeneous expression of cytokeratin 18, with significantly lower levels compared to the control group. A decrease in E-cadherin expression was also established (p < 0.05), which has prognostic value: metastatic SEBC cases showed a more pronounced decrease in E-cadherin levels (χ² = 8.8; p < 0.05). No correlation was found between the presence of EMT and breast cancer group affiliation (χ² = 0.4; p = 0.51), although SEBC demonstrated a higher EMT stage.https://ukrmedsci.com/index.php/visnyk/article/view/229secondary edematous breast cancer epithelial-mesenchymal transition (emt) e-cadherin immunohistochemistry n-cadherin vimentin cytokeratin 18 prognostic markers |
| spellingShingle | O.M. Bilyi І.І. Yakovtsova І.V. Ivakhno Peculiarities and prognostic significance of epithelial-mesenchymal transition in secondary edematous breast cancers Journal of V. N. Karazin Kharkiv National University: Series Medicine secondary edematous breast cancer epithelial-mesenchymal transition (emt) e-cadherin immunohistochemistry n-cadherin vimentin cytokeratin 18 prognostic markers |
| title | Peculiarities and prognostic significance of epithelial-mesenchymal transition in secondary edematous breast cancers |
| title_full | Peculiarities and prognostic significance of epithelial-mesenchymal transition in secondary edematous breast cancers |
| title_fullStr | Peculiarities and prognostic significance of epithelial-mesenchymal transition in secondary edematous breast cancers |
| title_full_unstemmed | Peculiarities and prognostic significance of epithelial-mesenchymal transition in secondary edematous breast cancers |
| title_short | Peculiarities and prognostic significance of epithelial-mesenchymal transition in secondary edematous breast cancers |
| title_sort | peculiarities and prognostic significance of epithelial mesenchymal transition in secondary edematous breast cancers |
| topic | secondary edematous breast cancer epithelial-mesenchymal transition (emt) e-cadherin immunohistochemistry n-cadherin vimentin cytokeratin 18 prognostic markers |
| url | https://ukrmedsci.com/index.php/visnyk/article/view/229 |
| work_keys_str_mv | AT ombilyi peculiaritiesandprognosticsignificanceofepithelialmesenchymaltransitioninsecondaryedematousbreastcancers AT ííyakovtsova peculiaritiesandprognosticsignificanceofepithelialmesenchymaltransitioninsecondaryedematousbreastcancers AT ívivakhno peculiaritiesandprognosticsignificanceofepithelialmesenchymaltransitioninsecondaryedematousbreastcancers |